LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Home・Listă Acțiuni・Edwards Lifesciences Corp

Edwards Lifesciences Corp

Deschisă

Sector Sănătate

69.13 0.83

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

68.56

Maxim

70.94

Indicatori cheie
By Trading Economics
Venit	14M 366M
Vânzări	30M 1.6B
P/E Medie Sector	39.81 103.001
EPS	0.7
Marjă de profit	22.472
Angajați	19,800
EBITDA	-59M 417M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+15.29 upside

Dividende
By Dow Jones
Următoarele câștiguri	23 oct. 2024

Statistici piață
By TradingEconomics
Capitalizare de piață	-289M 42B
Deschiderea anterioară	68.3
Închiderea anterioară	69.13

Sentimentul știrilor

By Acuity

38%

62%

74 / 365 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

68.24 / 69.92 Suport & Rezistență

Edwards Lifesciences Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

15 iul. 2024, 13:57 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences to Buy Innovalve for $300 Million

3 sept. 2024, 20:38 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3 sept. 2024, 20:37 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3 sept. 2024, 20:36 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

25 iul. 2024, 09:02 UTC

Câștiguri

Acțiuni populare

Stocks to Watch Thursday: Ford, IBM, Chipotle, American Airlines -- WSJ

25 iul. 2024, 08:40 UTC

Top știri

These Stocks Are Moving the Most Today: Ford, Tesla, Alphabet, Nvidia, Super Micro, IBM, ServiceNow, Chipotle, and More -- Barrons.com

24 iul. 2024, 20:17 UTC

Câștiguri

Edwards Lifesciences: Expects 2024 Edwards Sales Growth of 8% to 10% >EW

24 iul. 2024, 20:15 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

24 iul. 2024, 20:15 UTC

Câștiguri

Edwards Lifesciences 2Q Sales $1.39B >EW

24 iul. 2024, 20:15 UTC

Câștiguri

Edwards Lifesciences 2Q Net $366.3M >EW

24 iul. 2024, 20:15 UTC

Câștiguri

Edwards Lifesciences 2Q Adj EPS 70c >EW

24 iul. 2024, 20:15 UTC

Câștiguri

Edwards Lifesciences 2Q EPS 61c >EW

15 iul. 2024, 13:42 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences to Buy Innovalve for $300M

15 iul. 2024, 13:01 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences: SAPIEN M3 Remains on Track to Become First Approved Transfemoral TMVR System in Europe by End of 2025 >EW

15 iul. 2024, 13:01 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences: Acquisition Enhances TMVR Technologies to Address Large Unmet Structural Heart Patient Needs >EW

15 iul. 2024, 13:00 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences to Acquire Innovalve Bio Medical Ltd., Early-Stage Transcatheter Mitral Valve Replacement Co >EW

15 iul. 2024, 13:00 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences To Acquire Innovalve >EW

4 iun. 2024, 17:26 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3 iun. 2024, 13:26 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3 iun. 2024, 12:25 UTC

Top știri

Achiziții, Fuziuni, Preluări

Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- Update

3 iun. 2024, 11:03 UTC

Top știri

Achiziții, Fuziuni, Preluări

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash

3 iun. 2024, 10:40 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch

3 iun. 2024, 10:32 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson: Acquired Business Has About 4,500 Employees >BDX EW

3 iun. 2024, 10:31 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson: Acquired Business Generated More Than $900 Million Revenue in 2023 >BDX

3 iun. 2024, 10:31 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson: Deal Expands Portfolio of Smart Connected Care Solutions >BDX EW

3 iun. 2024, 10:30 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson to Buy Edwards Lifesciences Critical Care Product Group for $4.2 Billion >BDX EW

3 iun. 2024, 10:30 UTC

Achiziții, Fuziuni, Preluări

BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW

26 apr. 2024, 20:10 UTC

Câștiguri

This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss -- IBD

25 apr. 2024, 21:05 UTC

Câștiguri

Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff -- IBD

25 apr. 2024, 20:32 UTC

Câștiguri

Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff -- IBD

Comparație

Modificare preț

Edwards Lifesciences Corp Așteptări

Obiectiv de preț

By TipRanks

15.29% sus

Prognoză pe 12 luni

Medie 79 USD 15.29%

Maxim 91 USD

Minim 70 USD

În baza a 23 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruEdwards Lifesciences Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

23 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 23 analiști care au acordat evaluări ale acțiunilor Edwards Lifesciences Corp - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

68.24 / 69.92Suport & Rezistență

Bearish events outweigh bullish events.

The bullish and bearish events are balanced.

All events are bearish.

Sentiment

By Acuity

74 / 365 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

Despre Edwards Lifesciences Corp

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease. Its Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.